• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Matern Fetal Neonatal Med . The effect of real-time polymerase chain reaction cycle threshold values on perinatal outcomes of pregnant women with

tetano

Editor, Senior Moderator
J Matern Fetal Neonatal Med


. 2021 Mar 11;1-8.
doi: 10.1080/14767058.2021.1900105. Online ahead of print.
The effect of real-time polymerase chain reaction cycle threshold values on perinatal outcomes of pregnant women with COVID-19


Atakan Tanacan[SUP] 1 [/SUP], Ali Taner Anuk[SUP] 1 [/SUP], Seyit Ahmet Erol[SUP] 1 [/SUP], Huseyin Levent Keskin[SUP] 2 [/SUP], Orhan Altinboga[SUP] 1 [/SUP], Betul Yakistiran[SUP] 1 [/SUP], Sibel Aydogan[SUP] 3 [/SUP], Serpil Unlu[SUP] 4 [/SUP], Elif Gul Yapar Eyi[SUP] 1 [/SUP], Cuneyt Tayman[SUP] 5 [/SUP], Bedia Dinc[SUP] 3 [/SUP], Dilek Sahin[SUP] 2 [/SUP], Ozlem Moraloglu Tekin[SUP] 2 [/SUP]



Affiliations

Abstract

Objective: To evaluate the effect of cycle threshold (Ct) values on the pregnancy outcomes of women with coronavirus disease 2019 (COVID-19).
Materials and methods: This prospective cohort study was conducted on pregnant women with COVID-19. A real-time polymerase chain reaction (RT-PCR) assay of a nasopharyngeal and oropharyngeal specimen was used for the diagnosis. Initial Ct values for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RT-PCR tests were recorded. 22.9 was the 50th percentile Ct value of the study population. The study population was divided into two groups based on their Ct values: (1) Cases with Higher Ct values (Ct > 22.9)(n = 50) and (2) Cases with lower Ct values (Ct ? 22.9)(n = 55). Demographic features, clinical characteristics, disease progression, laboratory test results and pregnancy outcomes were compared between the groups. A receiver operating characteristic (ROC) curve was used to assess the performance of Ct values in predicting obstetric complications.
Results: Obstetric complication rate was significantly higher in cases with lower Ct values (p < .001). A significantly lower lymphocyte count together with higher ESR, procalcitonin and IL-6 values were observed in the cases with lower Ct values (p > .05). Additionally, a significantly higher NICU admission rate and longer hospital stays were present in the cases with lower Ct values (p > .05). The value in ROC curves with the best balance of sensitivity/specificity was 22.5 (85.7% sensitivity, 63.6% specificity).
Conclusion: Lower Ct values may be associated with an increased rate of obstetric complications in pregnant women with COVID-19. Physicians should be cautious in the management of cases with Ct levels below 22.5.

Keywords: COVID-19; SARS-CoV-2; cycle threshold; obstetric complications; pregnancy.
 
Back
Top Bottom